Endometrium-targeted mRNA-lipid nanoparticles for treating reproductive conditions
Researchers developed ligand-conjugated mRNA-lipid nanoparticles that selectively deliver mRNA to the endometrium. The therapy restored embryo implantation rates and showed improved safety in a murine endometrial injury model.
Why it mattersMRNA-LNP endometrium targeting improved implantation rates in a murine model; prioritize tissue-specific LNP designs for fertility and regenerative.